iPower to Participate in the Water Tower Research Fireside Chat Series on April 18
RANCHO CUCAMONGA, Calif., April 15, 2024 (GLOBE NEWSWIRE) — iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”), a tech and […]
CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)
BERKELEY HEIGHTS, N.J., April 15, 2024 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and […]
Microbot Medical Shares Status Following Recent Geopolitical Events
All Regulatory, Clinical, Operational and Pre-Commercial Activities Continue to Stay on Track Despite the On-going Situation in Israel Company Believes […]
Marathon Digital Holdings Appoints Manoj Narender Madnani as Managing Director for EMEA Expansion
Fort Lauderdale, FL, April 15, 2024 (GLOBE NEWSWIRE) — Marathon Digital Holdings, Inc. (NASDAQ:MARA) (“Marathon” or “Company”), one of the […]
Mobile-health Network Solutions Makes History as First APAC Telehealth Company Listed on US Stock Exchange
SINGAPORE, April 15, 2024 (GLOBE NEWSWIRE) — Mobile-health Network Solutions (Nasdaq: MNDR), a pioneering Asia-Pacific (APAC) telehealth provider, celebrates its […]
PetMeds® Announces Fiscal 2024 Third Quarter Financial Results and Completion of Financial Restatement
Fiscal 2024 3Q Revenue of $65.3 million, an 11% increase compared to last year including PetCareRx results.AutoShip & Save and […]
Blue World Acquisition Corporation Postponed the Extraordinary General Meeting to Approve the Business Combination with TOYO Solar Pending A Post-Effective Amendment to The Registration Statement
New York, April 15, 2024 (GLOBE NEWSWIRE) — Blue World Acquisition Corporation (“Blue World”) (NASDAQ: BWAQ) today announced that it […]
ACV Transportation Expands Services to Vehicles Purchased Outside of the ACV Platform
BUFFALO, N.Y., April 15, 2024 (GLOBE NEWSWIRE) — ACV (Nasdaq: ACVA), the leading digital automotive marketplace and data services partner […]
Reviva Reports Full Year 2023 Financial Results and Recent Business Highlights
– RECOVER-1 Phase 3 global trial successfully met all primary and secondary endpoints with statistically significant reductions across all major […]
Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo
SAN DIEGO, April 15, 2024 (GLOBE NEWSWIRE) — Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing […]
